GenomeX Consultancy Fee at Lahore PCR Lab

GenomeX Consultancy at Lahore PCR Lab

In the era of modern medicine, healthcare has transitioned from a generalized, one-size-fits-all approach to highly personalized, predictive, and preventive care. At the forefront of this medical revolution is genomic medicine, which analyzes an individual’s unique genetic blueprint to understand disease risk, diagnose rare conditions, and tailor highly specific treatment plans. Lahore PCR Lab, located in the heart of Lahore, Pakistan, has established itself as a premier institution for molecular diagnostics. Through its specialized GenomeX division, the lab offers comprehensive genetic counseling and advanced genomic testing services. The GenomeX Consultancy at Lahore PCR Lab is a dedicated clinical service designed to guide patients, families, and referring physicians through the complex landscape of genetic testing, variant interpretation, and personalized healthcare planning.

The GenomeX Consultancy is not merely a laboratory test; it is an all-encompassing clinical consultation led by experienced molecular pathologists, geneticists, and clinical consultants. Using cutting-edge technologies such as Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and chromosomal microarrays, the laboratory analyzes DNA, RNA, and chromosomes to identify genetic variations. The primary objective of the GenomeX Consultancy is to provide clinical clarity. Whether a patient is seeking to understand their hereditary cancer risk, investigating the genetic cause of a rare developmental disorder, or looking for pharmacogenomic insights to optimize medication efficacy, this consultancy acts as the essential bridge between complex molecular data and actionable clinical decisions.

Understanding the GenomeX Consultancy Fee at Lahore PCR Lab is crucial for patients planning their diagnostic journey. The fee structure is designed to reflect the highly specialized nature of genetic analysis, which requires advanced bioinformatics pipelines, state-of-the-art laboratory infrastructure, and the clinical expertise of multidisciplinary medical specialists. By investing in a GenomeX consultation, patients receive a thorough pre-test evaluation to determine the most cost-effective and clinically relevant genetic panels, followed by an in-depth post-test consultation. This structured approach prevents unnecessary, expensive testing and ensures that the genetic data is translated into a practical, life-saving medical management plan.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is key to maximizing the clinical utility of your GenomeX Consultancy at Lahore PCR Lab. Unlike routine biochemical blood tests, genetic counseling and molecular testing require preparation focused on clinical information rather than dietary restrictions. Patients should observe the following guidelines:

• Compile Family Medical History: Gather detailed medical information spanning at least three generations. Document any history of cancers, cardiovascular diseases, neurological disorders, congenital anomalies, or unexplained sudden deaths in the family.
• Gather Medical Records: Bring all relevant clinical notes, previous laboratory reports, pathology results, imaging studies (such as MRI, CT, or ultrasound reports), and current prescription lists.
• Identify Clinical Goals: Clearly define what you and your referring physician hope to achieve through genetic testing, such as identifying a disease cause, assessing future risks, or determining drug compatibility.
• No Dietary Restrictions: Fasting is generally not required for genetic testing unless specifically instructed by your consultant. You may eat, drink, and take your routine medications normally.
• Consent and Documentation: Be prepared to discuss and sign an informed consent form, which outlines the scope, limitations, benefits, and potential psychological impact of genetic testing.

During the Procedure

The GenomeX Consultancy process at Lahore PCR Lab is divided into distinct, patient-centered phases to ensure comprehensive care:

• Pre-Test Consultation: You will meet with a clinical genetics specialist in a private, comfortable environment. The consultant will review your medical history, construct a detailed family pedigree chart, and discuss the clinical indications for genetic testing.
• Test Selection: Based on the clinical evaluation, the consultant will recommend the most appropriate molecular test, such as targeted single-gene sequencing, a multi-gene panel, whole-exome sequencing (WES), or whole-genome sequencing (WGS). The associated GenomeX Consultancy Fee and testing costs will be explained transparently.
• Sample Collection: If you proceed with testing, a biological sample will be collected. This is typically a simple venipuncture to collect a peripheral blood sample in an EDTA tube, or a non-invasive buccal (cheek) swab. Both methods are safe, quick, and performed under strict sterile conditions.
• Bioinformatics and Analysis: The collected sample is processed in Lahore PCR Lab’s state-of-the-art molecular division. DNA is extracted, sequenced using high-throughput technology, and analyzed using advanced bioinformatics software to identify genetic variants.
• Post-Test Consultation: Once the report is ready, a follow-up consultation is scheduled. The consultant will explain the findings, distinguish between pathogenic mutations and benign variants, discuss clinical implications, and provide recommendations for medical management or family screening.

When is a GenomeX Consultancy Performed?

Hereditary Cancer Risk Assessment

Physicians frequently recommend a GenomeX Consultancy when a patient has a strong family history of malignancies, such as breast, ovarian, colorectal, or prostate cancer. Genetic counseling helps identify individuals who may carry pathogenic germline mutations in genes like BRCA1, BRCA2, or mismatch repair genes (associated with Lynch syndrome). Identifying these mutations early allows for proactive surveillance, prophylactic surgeries, or targeted chemoprevention, significantly reducing cancer mortality.

Prenatal and Preconception Screening

Prospective parents often seek GenomeX Consultancy to assess the risk of passing hereditary disorders to their offspring. This is particularly vital in regions with high rates of consanguineous marriages, where autosomal recessive conditions like Beta-Thalassemia, Cystic Fibrosis, and Spinal Muscular Atrophy are more prevalent. The consultation guides couples through carrier screening, preimplantation genetic testing, or prenatal diagnostic options to ensure informed reproductive choices.

Unexplained Developmental Delays or Congenital Anomalies

In pediatric medicine, children presenting with unexplained developmental delays, intellectual disabilities, autism spectrum disorders, or multiple congenital anomalies often undergo a GenomeX evaluation. When standard diagnostic modalities fail to provide answers, advanced genomic sequencing can pinpoint the underlying genetic etiology. Establishing a definitive molecular diagnosis ends the diagnostic odyssey for families and helps clinicians design targeted therapeutic and supportive interventions.

Pharmacogenomics and Personalized Therapy

Pharmacogenomics is the study of how an individual’s genetic makeup affects their response to drugs. A GenomeX Consultancy is highly beneficial for patients requiring medications with narrow therapeutic indices or high risk of adverse reactions, such as certain cardiovascular drugs, psychiatric medications, or oncological therapies. By analyzing genetic variants in metabolic enzymes (like the CYP450 superfamily), clinicians can prescribe the right drug at the optimal dose, minimizing side effects and maximizing treatment efficacy.

Cardiovascular and Rare Genetic Disorders

Unexplained cardiomyopathy, familial hypercholesterolemia, cardiac arrhythmias, and rare multi-system disorders often have a strong genetic basis. Physicians request a GenomeX consultation to evaluate patients presenting with these complex clinical features. Identifying the specific genetic variant helps confirm the diagnosis, stratify sudden cardiac death risk, guide therapeutic choices (such as implantable cardioverter-defibrillators), and screen at-risk family members.

What Does a GenomeX Consultancy Detect?

The GenomeX Consultancy, combined with advanced molecular diagnostics at Lahore PCR Lab, is capable of detecting a wide array of genetic variations and clinical markers, including:

• Pathogenic germline mutations in BRCA1 and BRCA2 genes associated with hereditary breast and ovarian cancer syndrome.
• Genetic variants in mismatch repair genes (MLH1, MSH2, MSH6, PMS2) indicative of Lynch syndrome.
• Carrier status for autosomal recessive disorders, including Beta-Thalassemia, Alpha-Thalassemia, and Cystic Fibrosis.
• Survival Motor Neuron 1 (SMN1) gene deletions responsible for Spinal Muscular Atrophy (SMA).
• Chromosomal aneuploidies, such as Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome).
• Microdeletion and microduplication syndromes via high-resolution chromosomal microarray analysis.
• Somatic mutations in cancer tissue (e.g., EGFR, KRAS, BRAF, ALK) to guide targeted oncological therapies.
• Pharmacogenomic variants in CYP2D6, CYP2C19, and CYP2C9 affecting the metabolism of antidepressants, clopidogrel, and warfarin.
• HLA-B*5701 allele status to predict severe hypersensitivity reactions to the antiviral drug abacavir.
• HLA-B*1502 allele status to assess the risk of Stevens-Johnson syndrome before initiating carbamazepine therapy.
• Mutations in the LDLR, APOB, and PCSK9 genes associated with familial hypercholesterolemia.
• Genetic variants linked to hereditary cardiomyopathies, including hypertrophic and dilated forms.
• Trinucleotide repeat expansions responsible for neurodegenerative disorders like Huntington’s disease.
• Mutations in the CFTR gene for comprehensive cystic fibrosis diagnosis and carrier screening.
• Genetic markers for hereditary hemochromatosis (HFE gene mutations) causing iron overload.
• F5 (Factor V Leiden) and F2 (Prothrombin) gene mutations associated with hereditary thrombophilia and increased blood clot risk.
• G6PD gene variants causing glucose-6-phosphate dehydrogenase deficiency and hemolytic anemia.
• JAK2 V617F mutation status for diagnosing myeloproliferative neoplasms.
• Y-chromosome microdeletions (AZFa, AZFb, AZFc regions) associated with male factor infertility.
• Variants of Uncertain Significance (VUS) that require advanced bioinformatic reclassification and clinical correlation.

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, we understand that waiting for genetic test results can be an anxious time for patients and their families. Because molecular and genomic testing involves complex laboratory processes—including DNA extraction, high-throughput sequencing, quality control checks, and detailed bioinformatic analysis—the turnaround time can vary. Typically, targeted single-gene tests or small PCR panels are completed within 7 to 10 working days, while comprehensive Next-Generation Sequencing (NGS) panels, Whole Exome Sequencing, or complex genomic analyses may take 3 to 4 weeks.

Lahore PCR Lab is committed to providing seamless and secure access to diagnostic reports. Once the genomic analysis is complete and has been thoroughly reviewed and signed off by our consultant molecular pathologists, patients are notified via SMS. Reports can be accessed online through the official Lahore PCR Lab web portal or mobile application, ensuring maximum convenience. Patients are highly encouraged to schedule their post-test GenomeX Consultancy session immediately upon receiving their reports to ensure a comprehensive, professional explanation of the findings and to discuss the next steps in their medical care.

GenomeX Consultancy Findings Overview

The following table provides an overview of key parameters evaluated during a GenomeX consultation and molecular testing, illustrating normal and potential abnormal findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
BRCA1 & BRCA2 Genes	No pathogenic variants or clinical deletions detected; average population risk.	Pathogenic germline mutations indicating high susceptibility to breast, ovarian, and pancreatic cancers.
Beta-Globin (HBB) Gene	Normal wild-type sequence; no mutations associated with hemoglobinopathies.	Heterozygous (carrier) or homozygous/compound heterozygous mutations causing Beta-Thalassemia.
Chromosomal Karyotype	Normal diploid chromosomal complement (46,XX or 46,XY) without structural abnormalities.	Aneuploidies (e.g., 47,XX,+21) or structural rearrangements like translocations and inversions.
CYP2C19 Genotype	Normal metabolizer status (e.g., *1/*1 allele combination); standard drug clearance.	Poor or ultra-rapid metabolizer status, requiring alternative dosing for drugs like clopidogrel.
EGFR Somatic Mutations	Wild-type sequence; no actionable somatic mutations detected in tumor tissue.	Activating mutations (e.g., Exon 19 deletions, L858R) indicating sensitivity to EGFR tyrosine kinase inhibitors.
Factor V Leiden (F5)	Wild-type genotype; normal blood clotting regulation.	Heterozygous or homozygous G1691A mutation, indicating increased risk of venous thromboembolism.
CFTR Gene	No pathogenic variants detected; normal chloride channel function.	Pathogenic mutations (e.g., delta-F508) causing Cystic Fibrosis or associated carrier status.
Y-Chromosome Microdeletions	No microdeletions detected in the AZF regions of the Y chromosome.	Microdeletions in AZFa, AZFb, or AZFc regions, explaining severe oligospermia or azoospermia.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for GenomeX Consultancy?

• Experienced Healthcare Professionals: Our team consists of highly qualified molecular pathologists, clinical geneticists, and bioinformaticians dedicated to clinical excellence.
• Patient-Focused Care: We prioritize patient comfort, understanding, and emotional support throughout the pre-test and post-test counseling phases.
• Quality Diagnostic Services: Lahore PCR Lab utilizes state-of-the-art molecular diagnostic technologies to ensure the highest levels of analytical accuracy and reproducibility.
• Professional Reporting: Our genomic reports are comprehensive, detailed, and structured to provide clear, actionable clinical insights for referring physicians.
• Modern Diagnostic Approach: We integrate advanced Next-Generation Sequencing (NGS) and bioinformatics pipelines to stay at the cutting edge of genomic medicine.
• Comfortable Environment: Our consultation rooms in Lahore provide a private, confidential, and compassionate setting for sensitive genetic discussions.
• Convenient Location: Easily accessible diagnostic facilities across Lahore, ensuring hassle-free sample collection and consultation scheduling.
• Commitment to Accurate Diagnosis: We adhere to rigorous international quality control standards to deliver diagnostic results you and your doctor can trust.